Sol-Gel Technologies Ltd.
General ticker "SLGL" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $392.7M (TTM average)
Sol-Gel Technologies Ltd. follows the US Stock Market performance with the rate: 39.4%.
Estimated limits based on current volatility of 3.4%: low 74.07$, high 79.28$
Factors to consider:
- Total employees count: 49 as of 2017
- Current price 57.7% above estimated high
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [16.68$, 46.85$]
- 2026-12-31 to 2027-12-31 estimated range: [10.37$, 30.34$]
Financial Metrics affecting the SLGL estimates:
- Negative: with PPE of -37.7 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Net income
- Negative: -0.75 < Inventory ratio change, % of 0
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
- Negative: Industry earnings per price (median), % of -14.62 <= 0
- Negative: Investing cash flow per share per price, % of -7.23 <= -4.45
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term SLGL quotes
Long-term SLGL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1.55MM | $11.54MM | $19.39MM |
| Operating Expenses | $30.86MM | $23.55MM | $26.98MM |
| Operating Income | $-29.30MM | $-12.01MM | $-7.59MM |
| Non-Operating Income | $2.07MM | $1.43MM | $1.47MM |
| R&D Expense | $23.54MM | $17.80MM | $22.70MM |
| Income(Loss) | $-27.24MM | $-10.58MM | $-6.13MM |
| Profit(Loss)* | $-27.24MM | $-10.58MM | $-6.13MM |
| Stockholders Equity | $38.64MM | $28.85MM | $22.81MM |
| Assets | $45.29MM | $35.85MM | $29.92MM |
| Operating Cash Flow | $-17.73MM | $-13.89MM | $0.32MM |
| Capital expenditure | $0.13MM | $0.00MM | $0.05MM |
| Investing Cash Flow | $-9.74MM | $26.69MM | $-8.58MM |
| Financing Cash Flow | $21.81MM | $0.00MM | $0.01MM |
| Earnings Per Share** | $-1.01 | $-0.38 | $-2.20 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.